#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
April Loui Email
SVP Quality and CMC Regulatory Affairs . ReCode Therapeutics
How to contact April Loui
Join and see April's contact info for free!Current Roles
Employees:
155Revenue:
$24MAbout
ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases. The Company's diverse pipeline includes lead programs for cystic fibrosis (CF) caused by nonsense mutations, and primary ciliary dyskinesia (PCD). ReCode has developed a non-viral delivery therapeutic platform that enables it to precisely deliver its medicines safely and effectively. The Company is leveraging its lipid nanoparticle and nucleic acid technologies across multiple modalities, including mRNA-mediated replacement therapies, first-in-class tRNA NanoCorrectors for diseases caused by nonsense mutations, and gene editing. For more information, visit www.recodetx.com or contact us at info@recodetx.com.ReCode Therapeutics Address
1140 O’Brien DriveMenlo Park, TX
United States